Lv1
20 积分 2021-11-10 加入
Advances in clinical trials on perioperative immune checkpoint inhibitors for resectable non-small cell lung cancer: A comprehensive review
3天前
已完结
Rapid Advances in Resectable Non–Small Cell Lung Cancer
3天前
已完结
Facts and hopes in neoadjuvant immunotherapy combinations in resectable non-small-cell lung cancer
3天前
已完结
New options for late-line treatment of metastatic colorectal cancer
7个月前
已完结
Therapeutic landscape and future direction of metastatic colorectal cancer
7个月前
已完结
Colorectal cancer
7个月前
已完结
Current advances in targeted therapy for metastatic colorectal cancer – Clinical translation and future directions
9个月前
已完结
Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial
11个月前
已关闭
Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial
11个月前
已完结
The oncology market for antibody–drug conjugates
1年前
已完结
皖公网安备34019202002308
